CGM: The Game-Changer in Diabetes Care

Published in Member Communities on September 24, 2025

Chris MoranBy Chris Moran, General Manager and Vice President, GEMCO Medical

For decades, people living with diabetes had one main way to check their blood sugar—fingerstick testing. A quick prick, a single number, a moment-in-time glimpse at glucose levels. Helpful? Yes. Complete? Not even close.

Today, diabetes management looks very different. Continuous glucose monitoring (CGM) has emerged as one of the most important advances in diabetes care, delivering round-the-clock insights that go far beyond the limitations of fingersticks. 

CGM isn’t a passing trend—it’s quickly becoming the gold standard in proactive, data-driven diabetes management. Patients gain freedom and peace of mind, providers gain valuable clinical insight, and better outcomes are more achievable than ever. 

What Exactly Is CGM—and How Does It Work? 

A continuous glucose monitoring system uses a tiny sensor inserted just under the skin to measure glucose levels in the body’s interstitial fluid. The sensor records readings every few minutes and automatically sends the data to a monitor, receiver, or smartphone app. 

Instead of relying on a few numbers each day from fingersticks, patients can monitor their glucose levels in real time, track trends, and receive alerts the moment something’s out of range—day or night. 

Popular systems like Dexcom G7 and Abbott FreeStyle Libre have made CGM simple, discreet, and more affordable than ever. Many patients describe it as life-changing. 

Abbott FreeStyle Libre System Dexcom G7 System

Why CGM Outperforms Traditional Fingersticks 

  1. Real-Time Glucose Data 
    No waiting. No guessing. Patients can see what’s happening right now with real-time monitoring—whether they’re exercising, eating, or sleeping. 
  2. Trend Tracking 
    CGM charts show where glucose has been and where it’s headed, making it easier to adjust food, insulin, and activity before problems occur. 
  3. Proactive Alerts 
    Smart alerts can warn patients and caregivers about high or low glucose before symptoms appear, helping prevent dangerous situations. 
  4. Greater Control 
    When patients can see their numbers all day, they better understand how meals, exercise, stress, and medication impact their glucose—often leading to healthier habits. 

These CGM benefits support more personalized and proactive diabetes management, reducing the risk of complications and improving overall well-being.

The Proof: CGM Delivers Better Outcomes 

CGM isn’t just convenient—it’s clinically proven to improve health outcomes. The American Diabetes Association reports that CGM use can: 

  • Reduce A1C levels 
  • Lower the risk of severe hypoglycemia 
  • Increase time-in-range (TIR)—the amount of time blood glucose stays within a healthy range 

One large-scale study found that CGM users spent 17% more time in range compared to those using traditional self-monitoring. That’s nearly four extra hours every day with safer glucose levels. 

Why Now Is the Time to Offer CGM 

A few years ago, CGM was harder to access—costly devices, limited insurance coverage, and sometimes complicated setup. Today, the landscape is very different: 

  • Expanded insurance coverage for more patients, including many with Type 2 diabetes 
  • Lower out-of-pocket costs 
  • Simpler insertion and wear—most sensors last 10–15 days and are virtually painless to apply 
  • Direct-to-smartphone technology for real-time readings without a separate receiver 

As a result, demand is growing fast—and DME providers who offer CGM now can strengthen their role in patient care while building recurring revenue streams. 

How GEMCO Medical Helps You Succeed with CGMs 

At GEMCO Medical, we’ve spent over 30 years helping healthcare providers deliver better diabetes care. We understand the unique challenges of offering new technology, and we’ve built our CGM program to make it as easy and profitable as possible for DMEs. 

Here’s what sets us apart: 

  • No Upfront Inventory Needed 
    We drop ship directly to your patients, so you don’t have to purchase or store products in advance. 
  • Recurring Revenue 
    CGM sensors and supplies are ordered every 30 or 90 days—creating a reliable resupply business. 
  • Expert Support 
    Our team helps you launch and grow your CGM offering with product training, marketing tools, and operational guidance. 
  • Trusted Partnerships 
    We work directly with leading manufacturers, such as Dexcom and Abbott, to ensure you and your patients receive top-tier technology and support. 

What This Means for Your Patients—and Your Business 

For patients, CGM is about confidence, safety, and control. For providers, it’s about delivering better care, increasing satisfaction, and building a loyal customer base. 

When you offer CGM through GEMCO Medical, your patients gain: 

  • Real-time insights that can prevent emergencies 
  • A deeper understanding of their diabetes 
  • The ability to make informed daily decisions 
  • Technology that fits into their lifestyle 

For your business, you gain: 

  • Differentiation from competitors 
  • Long-term recurring revenue 
  • Stronger patient relationships 
  • A proven, in-demand product category 

Looking Ahead 

The shift from fingersticks to continuous monitoring isn’t just an upgrade—it’s a transformation in how diabetes is managed. Providers who embrace CGM early will be better positioned to meet patient needs and capture market share. 

The future of diabetes care is real-time, connected, and proactive. And with GEMCO Medical as your partner, you can lead the way. 

Ready to Get Started? 

GEMCO Medical makes it easy to add CGM to your offerings—or scale the program you already have. Our team is here to guide you through every step, from onboarding to patient support. 

Let’s bring the benefits of CGM to more patients—together. 

Contact us today to learn more.


TAGS

  1. cgm
  2. cgms
  3. vendor
  4. vgm

From Our Experts

Jeff Kessler Named New Director of OPGA thumbnail Jeff Kessler Named New Director of OPGA OPGA is proud to announce that Jeff Kessler will be the director of OPGA effective October 1, 2025. O&P Advocacy in Action in Indiana thumbnail O&P Advocacy in Action in Indiana Learn how dedicated O&P professionals in Indiana are shaping orthotic legislation and improving patient care in prosthetics & orthotics. October Breast Cancer Awareness Month Activities & Education Guide thumbnail October Breast Cancer Awareness Month Activities & Education Guide Get inspired with impactful activity ideas for Breast Cancer Awareness Month as women's health providers. Amplify Marketing Efforts with AI thumbnail Amplify Marketing Efforts with AI Discover how to leverage AI in your marketing efforts to enhance personalization, optimize campaigns, and make data-driven decisions. Tyler Mahncke Attends NCART, U.S. Rehab, and iNRRTs Fly-In in Washington D.C. thumbnail Tyler Mahncke Attends NCART, U.S. Rehab, and iNRRTs Fly-In in Washington D.C. Tyler Mahncke shares his experience attending the NCART, U.S. Rehab, and iNRRTs Fly-In in Washington D.C. This event brought together around 40 attendees, including manufacturers, suppliers, and wheelchair users, to advocate for crucial issues affecting our industry. Jeff Bowman Joins VGM & Associates thumbnail Jeff Bowman Joins VGM & Associates VGM & Associates is pleased to announce that Jeff Bowman has joined VGM & Associates as Senior Vice President of Strategic Partnerships. Effective Fall Prevention for CRT Users: Key Strategies thumbnail Effective Fall Prevention for CRT Users: Key Strategies Fall Prevention Awareness Day is an important occasion for CRT providers, highlighting the critical role they play in ensuring the independence and safety of complex rehab technology (CRT) users. Fall Prevention Home Modifications: Safer Living thumbnail Fall Prevention Home Modifications: Safer Living Explore fall prevention strategies for home modification providers to enhance safety for older adults and those with mobility challenges.